Your browser is no longer supported. Please, upgrade your browser.
Neuronetics, Inc.
Index- P/E- EPS (ttm)-0.98 Insider Own5.40% Shs Outstand25.90M Perf Week-19.62%
Market Cap134.82M Forward P/E- EPS next Y-0.98 Insider Trans-6.85% Shs Float24.51M Perf Month-21.74%
Income-22.50M PEG- EPS next Q-0.30 Inst Own91.70% Short Float8.95% Perf Quarter-63.18%
Sales54.50M P/S2.47 EPS this Y7.80% Inst Trans0.59% Short Ratio4.23 Perf Half Y-53.16%
Book/sh3.75 P/B1.34 EPS next Y23.60% ROA-19.70% Target Price- Perf Year-19.36%
Cash/sh4.33 P/C1.16 EPS next 5Y- ROE-35.70% 52W Range4.62 - 22.43 Perf YTD-54.64%
Dividend- P/FCF- EPS past 5Y- ROI-38.70% 52W High-77.53% Beta2.44
Dividend %- Quick Ratio11.20 Sales past 5Y- Gross Margin79.10% 52W Low9.09% ATR0.44
Employees161 Current Ratio11.60 Sales Q/Q46.40% Oper. Margin-34.10% RSI (14)31.18 Volatility8.32% 6.59%
OptionableYes Debt/Eq0.36 EPS Q/Q29.90% Profit Margin-41.20% Rel Volume0.91 Prev Close4.86
ShortableYes LT Debt/Eq0.36 EarningsAug 03 BMO Payout- Avg Volume519.05K Price5.04
Recom1.40 SMA20-18.97% SMA50-28.01% SMA200-59.63% Volume474,409 Change3.70%
Oct-13-21Downgrade William Blair Outperform → Mkt Perform
Oct-13-21Downgrade BTIG Research Buy → Neutral
Jan-22-21Upgrade William Blair Mkt Perform → Outperform
Feb-06-20Initiated BTIG Research Buy $11
Jul-24-18Initiated Canaccord Genuity Buy
Oct-17-21 07:30PM  
Oct-14-21 06:30PM  
Oct-13-21 12:27PM  
Oct-12-21 04:15PM  
Oct-05-21 04:15PM  
Oct-04-21 08:40AM  
Sep-22-21 06:33PM  
Sep-21-21 12:49PM  
Sep-07-21 08:30AM  
Aug-17-21 08:31AM  
Aug-05-21 04:30PM  
Aug-04-21 02:01AM  
Aug-03-21 08:55AM  
Jul-29-21 08:30AM  
Jul-27-21 03:03PM  
Jul-21-21 01:53PM  
Jul-20-21 08:30AM  
Jul-14-21 08:15AM  
Jul-05-21 09:50AM  
Jun-23-21 05:29PM  
Jun-18-21 11:56AM  
Jun-09-21 08:00AM  
Jun-03-21 08:00AM  
Jun-01-21 08:00AM  
May-20-21 08:00AM  
May-18-21 12:30PM  
May-17-21 08:00AM  
May-06-21 08:26AM  
May-04-21 07:01PM  
May-03-21 08:00AM  
Apr-29-21 08:00AM  
Apr-20-21 08:00AM  
Apr-14-21 05:15PM  
Apr-01-21 04:05PM  
Mar-11-21 04:25PM  
Mar-09-21 08:00AM  
Mar-06-21 02:23AM  
Mar-03-21 08:00AM  
Mar-02-21 08:55AM  
Mar-01-21 10:12AM  
Feb-23-21 08:00AM  
Feb-16-21 07:00AM  
Feb-11-21 08:00AM  
Feb-10-21 07:00AM  
Feb-02-21 04:05PM  
Jan-28-21 10:30PM  
Jan-19-21 08:00AM  
Jan-14-21 05:06AM  
Jan-12-21 04:05PM  
Jan-11-21 12:29PM  
Jan-07-21 04:30PM  
Dec-14-20 09:55PM  
Dec-08-20 04:05PM  
Nov-30-20 04:05PM  
Nov-23-20 04:05PM  
Nov-12-20 04:05PM  
Nov-02-20 06:15PM  
Oct-26-20 12:31PM  
Oct-19-20 04:05PM  
Oct-15-20 10:59AM  
Oct-13-20 08:00AM  
Oct-05-20 08:00AM  
Oct-01-20 08:00AM  
Sep-29-20 08:00AM  
Sep-22-20 08:00AM  
Aug-31-20 11:04AM  
Aug-04-20 08:45AM  
Jul-28-20 12:33PM  
Jul-21-20 08:00AM  
Jul-17-20 04:05PM  
Jul-14-20 04:15PM  
Jun-26-20 07:00AM  
Jun-10-20 01:01PM  
Jun-04-20 04:30PM  
Jun-03-20 09:53AM  
May-12-20 05:21PM  
May-07-20 08:00AM  
May-05-20 07:30AM  
Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with psychiatric disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company sells its products through its sales and customer support team to psychiatrists. Neuronetics, Inc. was incorporated in 2003 and is headquartered in Malvern, Pennsylvania.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
CASCELLA ROBERTDirectorAug 30Buy6.7215,000100,85025,255Aug 31 05:04 PM
Furlong StephenCFOJul 28Sale13.086,56385,844250,449Jul 30 04:45 PM
Sullivan Keith JPresident and CEOJul 16Sale13.64931,269630,553Jul 19 05:32 PM
Sullivan Keith JPresident and CEOJul 15Sale13.4650,893684,913630,646Jul 19 05:32 PM
MACAN WILLIAM ANDREWSr. VP, GC, CCO and SecretaryJul 08Sale14.612,59137,860210,491Jul 09 05:41 PM
Furlong StephenCFOJun 04Sale15.002,47337,101257,012Jun 08 06:27 PM
CONLEY SHERYL LDirectorJun 01Sale14.036,20087,00539,672Jun 03 07:15 PM
CONLEY SHERYL LDirectorMay 28Sale13.786,80093,68445,872Jun 01 06:28 PM
Shook Bruce JosephDirectorMay 27Sale13.3515,200202,86829,937Jun 01 06:30 PM
Furlong StephenCFOMay 21Sale15.016,40696,171259,485May 24 05:12 PM
Furlong StephenCFOMay 20Sale15.0424,080362,222265,891May 24 05:12 PM
Harper GregoryVP of Prod. Dev. & OperationsMar 09Sale14.655,52480,927162,554Mar 11 05:09 PM
Furlong StephenCFOMar 09Sale14.646,52195,467289,971Mar 11 05:06 PM
MACAN WILLIAM ANDREWSr. VP, GC, CCO and SecretaryMar 09Sale14.658,537125,067213,082Mar 11 05:03 PM
Sullivan Keith JPresident and CEOFeb 05Sale17.9645,632819,551681,539Feb 09 06:10 PM
Sullivan Keith JPresident and CEOJan 26Sale18.8322,829429,870602,171Jan 28 09:42 PM
MACAN WILLIAM ANDREWSr. VP, GC, CCO and SecretaryJan 22Sale21.2812,696270,171188,453Jan 25 09:26 PM
Harper GregoryVP of Prod. Dev. & OperationsJan 21Sale18.212,96954,065150,993Jan 25 09:27 PM
Furlong StephenCFOJan 21Sale18.217,585138,123261,316Jan 25 09:26 PM